Vidal, from the George Washington University School of Medicine and Health Sciences in the Washington, D.C., and colleagues used the TriNetX U.S
Individuals assume full responsibility for their research protocols
The pathomechanisms by which prolactin impairs glucose homeostasis are unclear, some effects would rather enhance insulin sensitivity
The cardiovascular safety profile has been extensively evaluated in clinical trials involving thousands of patients, with overall findings favouring cardiovascular protection rather than harm
It must be discarded after this period
It has been suggested that GLP-1 receptor agonists might elicit hypoglycemia in healthy, hyperglycemic test subjects, indicating that their activity may possibly not be as glucose-dependent as was previously believed